Protalix BioTherapeutics, Inc. (AMEX:PLX)

CAPS Rating: 2 out of 5

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Featured Broker Partners


Advertisement